Home › Funds › Renaissance Technologies › AGL
Renaissance Technologies position in AGL
AGILON HEALTH INC · Health Care
Latest position (Q2 2026)152.21K sh
Reported value held$16.31M
Portfolio Weight0.02%
First reportedQ4 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 11.60K | $313.00K | New |
| Q2 2022 | 150.30K | $3.28M | New |
| Q4 2022 | 324.50K | $5.24K | New |
| Q1 2023 | 35.60K | $846 | Reduce |
| Q2 2023 | 1.68M | $29.12K | Add |
| Q3 2023 | 497.80K | $8.84K | Reduce |
| Q4 2023 | 87.50K | $1.10K | Reduce |
| Q1 2024 | 284.80K | $1.74K | Add |
| Q3 2024 | 181.60K | $713.69K | New |
| Q4 2024 | 463.30K | $880.27K | Add |
| Q1 2025 | 1.29M | $5.59M | Add |
| Q2 2025 | 850.00K | $1.96M | Reduce |
| Q3 2025 | 1.46M | $1.50M | Add |
| Q4 2025 | 2.37M | $1.63M | Add |
| Q1 2026 | 149.04K | $1.18M | Reduce |
| Q2 2026 | 152.21K | $16.31M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding AGL
- Morgan Stanley 2.01M sh · $215.56M · Q2 2026
- BlackRock Inc 1.15M sh · $122.88M · Q2 2026
- AQR Capital Management 692.54K sh · $74.23M · Q2 2026
- Goldman Sachs Group 686.79K sh · $73.61M · Q2 2026
- Marshall Wace 468.29K sh · $50.19M · Q2 2026
- D. E. Shaw & Co 390.15K sh · $41.82M · Q2 2026
- Charles Schwab Investment Management 348.96K sh · $37.40M · Q2 2026
- Geode Capital Management 314.17K sh · $33.68M · Q2 2026
- Citadel Advisors 184.57K sh · $19.78M · Q2 2026
- Invesco Ltd 133.14K sh · $14.27M · Q2 2026
- Two Sigma Investments 125.71K sh · $13.47M · Q2 2026